| Authors: |
Pinter T; Department of Oncoradiology, Petz Aladár Teaching Hospital, Györ, Hungary. Electronic address: pinterbely@gmail.com., Klippel Z; Clinical Development, Amgen Inc, Thousand Oaks, CA., Cesas A; Department of Medical Oncology, Klaipeda University Hospital, Klaipeda, Lithuania., Croitoru A; Department of Medical Oncology, Fundeni Clinical Institute, Bucharest, Romania., Decaestecker J; Department of Oncology, AZ Delta Hospital, Roeselare, Belgium., Gibbs P; Department of Oncology, The Western Hospital, Footscray, Victoria, Australia., Hotko Y; Uzhgorod Regional Oncology Dispensary, Uzhgorod National University, Uzhgorod, Ukraine., Jassem J; Department of Oncology and Radiotherapy, Medical University Gdansk, Gdansk, Poland., Kurteva G; Clinic of Medical Oncology, Specialized Hospital for Active Treatment in Oncology Sofia, Sofia, Bulgaria., Novotny J; Department of Oncology, Institute of Oncology and Rehabilitation, Nová Ves pod Pleší, Czech Republic., O'Reilly S; Department of Medical Oncology, Ireland Cooperative Oncology Research Group, Dublin, Ireland., Salek T; Department of Clinical Oncology, National Cancer Institute, Bratislava, Slovakia., Reiner M; Global Biostatistical Sciences, Amgen Inc, Thousand Oaks, CA., Morrow PK; Clinical Development, Amgen Inc, Thousand Oaks, CA., Choi MR; Clinical Development, Amgen Inc, Thousand Oaks, CA., Whittaker S; Clinical Development, Amgen Inc, Thousand Oaks, CA., Blanke C; Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health & Sciences University, Portland, OR. |
